Αποτελέσματα Αναζήτησης
We will discuss the potential use of cannabinoids for treatment of cancer, focusing on primary outcome/care—tumor shrinkage and eradication, as well as secondary outcome/palliative care—improvement of life quality, including pain, appetite, sleep, and many more factors.
- Cannabinoids in cancer treatment: Therapeutic potential and legislation ...
In cancer patients, cannabinoids have primarily been used as...
- Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline
Clinicians should recommend against using cannabis or...
- Cannabinoids in cancer treatment: Therapeutic potential and legislation ...
13 Μαρ 2024 · Cannabis and/or cannabinoid access and use by adults with cancer has outpaced the science supporting their clinical use. This guideline provides strategies for open, nonjudgmental communication between clinicians and adults with cancer about the use of cannabis and/or cannabinoids.
13 Μαΐ 2022 · Summary. The current consensus is that, right now, there isn’t a large enough body of evidence to prove that cannabis (or any of its active compounds or derivatives) can reliably treat any form of cancer but the medical use of cannabis to treat cancer-related chronic pain is approved in the UK.
13 Μαρ 2024 · Adults with cancer using cannabis or cannabinoids should understand that the clinical evidence to support their use as cancer-directed therapy in humans is lacking.
11 Μαρ 2022 · The following chapters provide an overview of the preclinical evidence on the effect of cannabinoids on cancer growth and metastasis, with the most relevant cannabinoid targets summarised in...
In cancer patients, cannabinoids have primarily been used as a part of palliative care to alleviate pain, relieve nausea and stimulate appetite. In addition, numerous cell culture and animal studies showed antitumor effects of cannabinoids in various cancer types.
1 Μαΐ 2024 · Clinicians should recommend against using cannabis or cannabinoids as a cancer-directed treatment unless within the context of a clinical trial. Cannabis and/or cannabinoids may improve refractory, chemotherapy-induced nausea and vomiting when added to guideline-concordant antiemetic regimens.
